Transaction · 0001829126-26-009544

Baumann Oliver Rolf

Baumann Oliver Rolf, DIR, reported an open-market or private purchase at Veraxa Biotech AG - Post de-SPAC involving 50000.000000 shares for an estimated $75000.00. Reported holdings after the transaction were 5773618.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
VRXAVeraxa Biotech AG - Post de-SPAC
Trade date
Aug 27, 2026
Filing date
Aug 31, 2026
View on SEC Insider profile
Estimated value$75.0kShares × reported price
Shares traded50.0k$1.50 per share
Holdings after5.77MIndirect · See Footnote
% of reported position traded0.87%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 5,723,618 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

VRXA price since this filing

Daily closing prices, with the filing date and available return windows
VRXA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d +30.4%30d -7.4%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001829126-26-009544
Ordinary Shares
Transaction date
Aug 27, 2026
Filed Aug 31, 2026, 08:10 PM · 4d delay
Shares
50,000 sh
$1.50 per share
Estimated value
$75.0k
Computed from shares × price
Holdings after
5,773,618 sh
Indirect · See Footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Director Buy
Filing-only score

+18 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG.

Original filing · 0001829126-26-009544
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

VRXA